Tag Archives: Katsuhiko Muraki

Research: Impaired TRPM3 ion channel function found in ME/CFS & Long COVID

Posted on 08/20/2022 by wames

TRPM3 dysfunction in post COVID-19 condition and ME/CFS patients   Research from the NCNED in Australia, using their Electrophysiology ‘Patch Clamp’ technique, concludes: The results of this investigation suggest that post COVID-19 condition patients may have impaired TRPM3 ion channel … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Research: Impaired TRPM3 ion channel function found in ME/CFS & Long COVID

Treatment research: …restoration using Naltrexone in natural killer cells of ME/CFS patients

Posted on 02/23/2022 by wames

Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients, by Natalie Eaton-Fitch, Stanley Du Preez, Hélène Cabanas, Katsuhiko Muraki, Donald Staines & Sonya Marshall-Gradisnik in Journal of Translational Medicine volume 20, … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on Treatment research: …restoration using Naltrexone in natural killer cells of ME/CFS patients

Research: Potential therapeutic benefit of Low Dose Naltrexone in ME/CFS

Posted on 07/16/2021 by wames

Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: role of Transient Receptor Potential Melastatin 3 Ion channels in pathophysiology and treatment, by Helene Cabanas,  Katsuhiko Muraki,  Natalie Eaton-Fitch,  Donald Ross Staines and Sonya Marshall-Gradisnik in … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Research: Potential therapeutic benefit of Low Dose Naltrexone in ME/CFS

Naltrexone restores impaired Transient Receptor Potential Melastatin 3 ion channel function in Natural Killer Cells from ME/CFS

Posted on 10/31/2019 by wames

Naltrexone restores impaired Transient Receptor Potential Melastatin 3 ion channel function in Natural Killer Cells from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients, by Helene Cabanas,  Katsuhiko Muraki,  Donald Staines and Sonya Marshall-Gradisnik in Front. Immunol., 31 October 2019 [https://doi.org/10.3389/fimmu.2019.02545]   Research … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on Naltrexone restores impaired Transient Receptor Potential Melastatin 3 ion channel function in Natural Killer Cells from ME/CFS

Validation of impaired TRPM3 ion channel activity in natural killer cells from CFS/ME

Posted on 05/21/2019 by wames

Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients, by H Cabanas, K Muraki, C Balinas, N Eaton-Fitch, D Staines, S Marshall-Gradisnik in Mol Med. 2019 Apr … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on Validation of impaired TRPM3 ion channel activity in natural killer cells from CFS/ME

Loss of transient receptor potential Melastatin 3 ion channel function in natural killer cells from CFS/ME

Posted on 08/29/2018 by wames

Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from CFS/ME patients by Hélène Cabanas, Katsuhiko Muraki, Natalie Eaton, Cassandra Balinas, Donald Staines and Sonya Marshall-Gradisnik in Molecular Medicine 2018 24:44 [Published: 14 August 2018] Research abstract: … Continue reading →

Posted in News | Tagged , , , , , , , , , , , | Comments Off on Loss of transient receptor potential Melastatin 3 ion channel function in natural killer cells from CFS/ME